care pharma (romford) ltd Company Information
Company Number
07931656
Website
-Registered Address
unit 1c bourne court,, southend road, woodford green, IG8 8HD
Industry
Other human health activities
Telephone
-
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
khalid khan 75%
fouzia khan 25%
care pharma (romford) ltd Estimated Valuation
Pomanda estimates the enterprise value of CARE PHARMA (ROMFORD) LTD at £1.1m based on a Turnover of £2m and 0.57x industry multiple (adjusted for size and gross margin).
care pharma (romford) ltd Estimated Valuation
Pomanda estimates the enterprise value of CARE PHARMA (ROMFORD) LTD at £409.1k based on an EBITDA of £89k and a 4.59x industry multiple (adjusted for size and gross margin).
care pharma (romford) ltd Estimated Valuation
Pomanda estimates the enterprise value of CARE PHARMA (ROMFORD) LTD at £39.8k based on Net Assets of £110.6k and 0.36x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Care Pharma (romford) Ltd Overview
Care Pharma (romford) Ltd is a live company located in woodford green, IG8 8HD with a Companies House number of 07931656. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2012, it's largest shareholder is khalid khan with a 75% stake. Care Pharma (romford) Ltd is a established, small sized company, Pomanda has estimated its turnover at £2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Care Pharma (romford) Ltd Health Check
Pomanda's financial health check has awarded Care Pharma (Romford) Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
6 Weak
Size
annual sales of £2m, make it larger than the average company (£682.6k)
- Care Pharma (romford) Ltd
£682.6k - Industry AVG
Growth
3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (5.8%)
- Care Pharma (romford) Ltd
5.8% - Industry AVG
Production
with a gross margin of 36.1%, this company has a comparable cost of product (36.1%)
- Care Pharma (romford) Ltd
36.1% - Industry AVG
Profitability
an operating margin of 4.4% make it less profitable than the average company (5.6%)
- Care Pharma (romford) Ltd
5.6% - Industry AVG
Employees
with 17 employees, this is similar to the industry average (18)
17 - Care Pharma (romford) Ltd
18 - Industry AVG
Pay Structure
on an average salary of £25.1k, the company has an equivalent pay structure (£25.1k)
- Care Pharma (romford) Ltd
£25.1k - Industry AVG
Efficiency
resulting in sales per employee of £116.3k, this is more efficient (£46.2k)
- Care Pharma (romford) Ltd
£46.2k - Industry AVG
Debtor Days
it gets paid by customers after 52 days, this is later than average (23 days)
- Care Pharma (romford) Ltd
23 days - Industry AVG
Creditor Days
its suppliers are paid after 30 days, this is slower than average (17 days)
- Care Pharma (romford) Ltd
17 days - Industry AVG
Stock Days
it holds stock equivalent to 31 days, this is more than average (10 days)
- Care Pharma (romford) Ltd
10 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (114 weeks)
0 weeks - Care Pharma (romford) Ltd
114 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 90.8%, this is a higher level of debt than the average (25%)
90.8% - Care Pharma (romford) Ltd
25% - Industry AVG
CARE PHARMA (ROMFORD) LTD financials
Care Pharma (Romford) Ltd's latest turnover from September 2023 is estimated at £2 million and the company has net assets of £110.6 thousand. According to their latest financial statements, Care Pharma (Romford) Ltd has 17 employees and maintains cash reserves of £2.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 17 | 17 | 17 | 17 | 16 | 17 | 13 | 9 | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 9,053 | 12,071 | 16,518 | 20,967 | 26,421 | 29,406 | 29,858 | 33,257 | 30,859 | 27,789 | 27,693 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 9,053 | 12,071 | 16,518 | 20,967 | 26,421 | 29,406 | 29,858 | 33,257 | 30,859 | 27,789 | 27,693 | 0 |
Stock & work in progress | 110,000 | 92,000 | 92,000 | 92,000 | 88,489 | 94,631 | 91,637 | 81,521 | 76,192 | 58,826 | 48,500 | 0 |
Trade Debtors | 282,128 | 5,592 | 145,884 | 251,640 | 235,370 | 212,697 | 203,872 | 171,006 | 163,467 | 73,823 | 39,733 | 0 |
Group Debtors | 642,496 | 649,538 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 151,665 | 220,324 | 548,768 | 230,731 | 17,745 | 23,394 | 0 | 21,981 | 17,252 | 0 | 0 | 0 |
Cash | 2,319 | 20,560 | 25,949 | 25,571 | 172,690 | 93,668 | 95,592 | 59,547 | 37,982 | 57,279 | 25,790 | 0 |
misc current assets | 0 | 0 | 63,428 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,188,608 | 988,014 | 876,029 | 599,942 | 514,294 | 424,390 | 391,101 | 334,055 | 294,893 | 189,928 | 114,023 | 0 |
total assets | 1,197,661 | 1,000,085 | 892,547 | 620,909 | 540,715 | 453,796 | 420,959 | 367,312 | 325,752 | 217,717 | 141,716 | 0 |
Bank overdraft | 59,122 | 175,674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 104,229 | 312,045 | 256,779 | 275,207 | 267,819 | 237,301 | 252,521 | 182,535 | 157,280 | 258,311 | 161,234 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 202,818 | 135,781 | 262,310 | 190,928 | 29,653 | 34,697 | 0 | 85,530 | 108,350 | 0 | 0 | 0 |
total current liabilities | 366,169 | 623,500 | 519,089 | 466,135 | 297,472 | 271,998 | 252,521 | 268,065 | 265,630 | 258,311 | 161,234 | 0 |
loans | 720,939 | 275,941 | 240,406 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 4,229 | 4,229 | 4,229 | 4,229 | 4,703 | 4,675 | 5,266 | 4,483 | 0 | 0 | 0 |
total long term liabilities | 720,939 | 280,170 | 244,635 | 54,229 | 4,229 | 4,703 | 4,675 | 5,266 | 4,483 | 0 | 0 | 0 |
total liabilities | 1,087,108 | 903,670 | 763,724 | 520,364 | 301,701 | 276,701 | 257,196 | 273,331 | 270,113 | 258,311 | 161,234 | 0 |
net assets | 110,553 | 96,415 | 128,823 | 100,545 | 239,014 | 177,095 | 163,763 | 93,981 | 55,639 | -40,594 | -19,518 | 0 |
total shareholders funds | 110,553 | 96,415 | 128,823 | 100,545 | 239,014 | 177,095 | 163,763 | 93,981 | 55,639 | -40,594 | -19,518 | 0 |
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 3,018 | 4,447 | 4,449 | 5,454 | 3,787 | 6,449 | 6,511 | 7,231 | 5,397 | 6,392 | ||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Tax | ||||||||||||
Stock | 18,000 | 0 | 0 | 3,511 | -3,148 | 2,994 | 10,116 | 5,329 | 17,366 | 10,326 | 48,500 | 0 |
Debtors | 200,835 | 180,802 | 212,281 | 229,256 | 49,243 | 32,219 | 10,885 | 12,268 | 106,896 | 34,090 | 39,733 | 0 |
Creditors | -207,816 | 55,266 | -18,428 | 7,388 | 15,298 | -15,220 | 69,986 | 25,255 | -101,031 | 97,077 | 161,234 | 0 |
Accruals and Deferred Income | 67,037 | -126,529 | 71,382 | 161,275 | 29,653 | 34,697 | -85,530 | -22,820 | 108,350 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -4,229 | 0 | 0 | 0 | -446 | 28 | -591 | 783 | 4,483 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 444,998 | 35,535 | 190,406 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | -18,241 | -5,389 | 378 | -147,119 | 77,098 | -1,924 | 36,045 | 21,565 | -19,297 | 31,489 | 25,790 | 0 |
overdraft | -116,552 | 175,674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 98,311 | -181,063 | 378 | -147,119 | 77,098 | -1,924 | 36,045 | 21,565 | -19,297 | 31,489 | 25,790 | 0 |
care pharma (romford) ltd Credit Report and Business Information
Care Pharma (romford) Ltd Competitor Analysis
Perform a competitor analysis for care pharma (romford) ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in IG8 area or any other competitors across 12 key performance metrics.
care pharma (romford) ltd Ownership
CARE PHARMA (ROMFORD) LTD group structure
Care Pharma (Romford) Ltd has no subsidiary companies.
Ultimate parent company
CARE PHARMA (ROMFORD) LTD
07931656
care pharma (romford) ltd directors
Care Pharma (Romford) Ltd currently has 2 directors. The longest serving directors include Mr Khalid Khan (Oct 2019) and Mr Khalid Khan (Oct 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Khalid Khan | England | 52 years | Oct 2019 | - | Director |
Mr Khalid Khan | England | 52 years | Oct 2019 | - | Director |
P&L
September 2023turnover
2m
+50%
operating profit
86k
0%
gross margin
36.2%
-2.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
110.6k
+0.15%
total assets
1.2m
+0.2%
cash
2.3k
-0.89%
net assets
Total assets minus all liabilities
care pharma (romford) ltd company details
company number
07931656
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
February 2012
age
12
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
September 2023
address
unit 1c bourne court,, southend road, woodford green, IG8 8HD
accountant
CLEAR BOOK ACCOUNTANTS LTD
auditor
-
care pharma (romford) ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to care pharma (romford) ltd. Currently there are 5 open charges and 0 have been satisfied in the past.
care pharma (romford) ltd Companies House Filings - See Documents
date | description | view/download |
---|